CONTENTS
Issue 91 | February 2020
In association with
What's next for the EU's flagship pharma projects funded by Horizon 2020?
The US is considering price-matching with the rest of the developed world
Valisure is taking an unusual approach to ensure the quality of the drugs it distributes
What does ‘ageing’ mean when it comes to drug development?
NASA funded projects are looking for ways to protect health during deep space missions
The resurrection of aducanumab has raised questions about the drugs efficacy
How is big pharma addressing rare conditions like EDS?
What is pharma's role in improving global access to medicine?
Turning attention towards patient benefits with IDMP data standards implementation